Treace Medical Concepts TMCI
NASDAQ TMCI
$4.53 -0.10 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

Treace Medical Concepts (TMCI) Profit After Tax Growth (3y) (2023 - 2026)

Analysis

Treace Medical Concepts (TMCI) Profit After Tax Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -12.28%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 21.98%
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 22.89%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 20.02%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 49.66%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -7.65%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 29.05%
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 15.46%
10 Treace Medical Concepts 312.82 Mn 267.20 Mn 35.61 Mn -9.02%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.02%
Mar 31, 2026 -10.11%
Dec 31, 2025 -28.44%
Sep 30, 2025 -10.31%
Jun 30, 2025 -0.33%
Mar 31, 2025 -20.78%
Dec 31, 2024 56.34%
Sep 30, 2024 -33.76%
Jun 30, 2024 -60.98%
Mar 31, 2024 -97.29%
Dec 31, 2023 -73.21%
Sep 30, 2023 -87.57%
Jun 30, 2023 -83.90%
Mar 31, 2023 -103.05%